Literature DB >> 18932067

Carrier screening and prenatal diagnosis of hemoglobinopathies. A study of indigenous and immigrant couples in northern Greece, over the last 5 years.

Stamatia Theodoridou1, Michael Alemayehou, Nikolaos Prappas, Olga Karakasidou, Vasiliki Aletra, Eleni Plata, Panagiotis Tsaftaridis, Photini Karababa, Marina Boussiou, Klio Sinopoulou, Anna Hatzi, Ersi Voskaridou, Afroditi Loutradi, Anna Manitsa.   

Abstract

Hemoglobinopathies constitute the most frequent monogenic disorders worldwide and thalassemias are the most frequent genetic disorders in Greece. Over a 5-year period (2002-2006), 1,375 couples were screened for hemoglobinopathies and counseled at our Thalassaemia Prevention Unit, Hippokration Hospital, Thessaloniki, Greece. In 148 cases (10.7%), both partners carried an abnormal hemoglobin (Hb) gene and genetic counseling was offered. One hundred out of 116 pregnancies were at-risk of giving birth to an offspring carrying either the homozygous or double heterozygous forms of the mutations under discussion. The remaining 16 pregnancies involved couples who were heterozygous for mutations that did not cause severe clinical disease, and were exempted from prenatal diagnosis. Twenty-six fetuses were found to be homozygotes or double heterozygotes for clinically significant mutations. These couples were informed of the danger of having an affected child but the termination or continuation of the pregnancy was left to the couples to decide. Nevertheless, all the couples preferred to terminate the pregnancies. The National Thalassaemia Prevention Programme has effectively decreased the incidence of thalassemia major and sickle cell syndromes in Greece.

Entities:  

Mesh:

Year:  2008        PMID: 18932067     DOI: 10.1080/03630260802341745

Source DB:  PubMed          Journal:  Hemoglobin        ISSN: 0363-0269            Impact factor:   0.849


  5 in total

Review 1.  Carrier screening for beta-thalassaemia: a review of international practice.

Authors:  Nicole E Cousens; Clara L Gaff; Sylvia A Metcalfe; Martin B Delatycki
Journal:  Eur J Hum Genet       Date:  2010-06-23       Impact factor: 4.246

2.  At-risk marriages after compulsory premarital testing and counseling for β-thalassemia and sickle cell disease in Saudi Arabia, 2005-2006.

Authors:  Fahad M Alswaidi; Ziad A Memish; Sarah J O'Brien; Nasser A Al-Hamdan; Faisal M Al-Enzy; Osamah A Alhayani; Ali M Al-Wadey
Journal:  J Genet Couns       Date:  2011-08-09       Impact factor: 2.537

3.  High resolution melting curve analysis targeting the HBB gene mutational hot-spot offers a reliable screening approach for all common as well as most of the rare beta-globin gene mutations in Bangladesh.

Authors:  Md Tarikul Islam; Suprovath Kumar Sarkar; Nusrat Sultana; Mst Noorjahan Begum; Golam Sarower Bhuyan; Shezote Talukder; A K M Muraduzzaman; Md Alauddin; Mohammad Sazzadul Islam; Pritha Promita Biswas; Aparna Biswas; Syeda Kashfi Qadri; Tahmina Shirin; Bilquis Banu; Salma Sadya; Manzoor Hussain; Golam Sarwardi; Waqar Ahmed Khan; Mohammad Abdul Mannan; Hossain Uddin Shekhar; Emran Kabir Chowdhury; Abu Ashfaqur Sajib; Sharif Akhteruzzaman; Syed Saleheen Qadri; Firdausi Qadri; Kaiissar Mannoor
Journal:  BMC Genet       Date:  2018-01-02       Impact factor: 2.797

4.  Rapid detection of pathological mutations and deletions of the haemoglobin beta gene (HBB) by High Resolution Melting (HRM) analysis and Gene Ratio Analysis Copy Enumeration PCR (GRACE-PCR).

Authors:  Andrew Turner; Jurgen Sasse; Aniko Varadi
Journal:  BMC Med Genet       Date:  2016-10-19       Impact factor: 2.103

5.  Assessment of Factors Associated with the Effectiveness of Premarital Screening for Hemoglobinopathies in the South of Saudi Arabia.

Authors:  Ibrahim M Gosadi; Gassem A Gohal; Alanoud E Dalak; Anas A Alnami; Norah A Aljabri; Atyaf J Zurayyir
Journal:  Int J Gen Med       Date:  2021-06-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.